Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1979 1
1980 1
1981 1
1983 1
1985 2
1986 1
1988 2
1989 1
1991 2
1992 3
1993 2
1994 3
1995 1
1996 3
1997 2
1998 2
1999 3
2000 5
2001 2
2002 7
2003 2
2004 5
2005 2
2006 5
2007 2
2008 4
2009 5
2010 6
2011 4
2012 15
2013 7
2014 15
2015 18
2016 20
2017 17
2018 10
2019 18
2020 15
2021 16
2022 13
2023 12
2024 12
2025 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

251 results

Results by year

Filters applied: . Clear all
Page 1
CXCR6 expressing T cells: Functions and role in the control of tumors.
Mabrouk N, Tran T, Sam I, Pourmir I, Gruel N, Granier C, Pineau J, Gey A, Kobold S, Fabre E, Tartour E. Mabrouk N, et al. Among authors: fabre e. Front Immunol. 2022 Oct 12;13:1022136. doi: 10.3389/fimmu.2022.1022136. eCollection 2022. Front Immunol. 2022. PMID: 36311728 Free PMC article. Review.
Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY): a randomised, double-blind, placebo-controlled, phase 3 trial.
Nakagawa K, Garon EB, Seto T, Nishio M, Ponce Aix S, Paz-Ares L, Chiu CH, Park K, Novello S, Nadal E, Imamura F, Yoh K, Shih JY, Au KH, Moro-Sibilot D, Enatsu S, Zimmermann A, Frimodt-Moller B, Visseren-Grul C, Reck M; RELAY Study Investigators. Nakagawa K, et al. Lancet Oncol. 2019 Dec;20(12):1655-1669. doi: 10.1016/S1470-2045(19)30634-5. Epub 2019 Oct 4. Lancet Oncol. 2019. PMID: 31591063 Clinical Trial.
Immunotherapy for Solid Tumors.
de Saint Basile H, Maaradji Z, Fabre E. de Saint Basile H, et al. Among authors: fabre e. Cancers (Basel). 2023 Mar 8;15(6):1646. doi: 10.3390/cancers15061646. Cancers (Basel). 2023. PMID: 36980532 Free PMC article.
Exploration of nuclear body-enhanced sumoylation reveals that PML represses 2-cell features of embryonic stem cells.
Tessier S, Ferhi O, Geoffroy MC, González-Prieto R, Canat A, Quentin S, Pla M, Niwa-Kawakita M, Bercier P, Rérolle D, Tirard M, Therizols P, Fabre E, Vertegaal ACO, de Thé H, Lallemand-Breitenbach V. Tessier S, et al. Among authors: fabre e. Nat Commun. 2022 Sep 29;13(1):5726. doi: 10.1038/s41467-022-33147-6. Nat Commun. 2022. PMID: 36175410 Free PMC article.
Differential predictive value of resident memory CD8+T cell subpopulations in patients with non-small-cell lung cancer treated by immunotherapy.
Paolini L, Tran T, Corgnac S, Villemin JP, Wislez M, Arrondeau J, Johannes L, Ulmer J, Vieillard LV, Pineau J, Gey A, Quiniou V, Barennes P, Pham HP, Gruel N, Hasan M, Libri V, Mella S, De Percin S, Boudou-Rouquette P, Caidi A, Cremer I, Blons H, Leroy K, Laurent-Puig P, De Saint Basile H, Gibault L, Ravel P, Mami-Chouaib F, Goldwasser F, Fabre E, Damotte D, Tartour E. Paolini L, et al. Among authors: fabre e. J Immunother Cancer. 2024 Dec 3;12(12):e009440. doi: 10.1136/jitc-2024-009440. J Immunother Cancer. 2024. PMID: 39631852 Free PMC article.
[Surgery for small-cell lung cancer].
Al Zreibi C, Gibault L, Fabre E, Le Pimpec-Barthes F. Al Zreibi C, et al. Among authors: fabre e. Rev Mal Respir. 2021 Oct;38(8):840-847. doi: 10.1016/j.rmr.2021.05.008. Epub 2021 Jun 5. Rev Mal Respir. 2021. PMID: 34099357 Review. French.
Nuclear transport.
Fabre E, Hurt EC. Fabre E, et al. Curr Opin Cell Biol. 1994 Jun;6(3):335-42. doi: 10.1016/0955-0674(94)90023-x. Curr Opin Cell Biol. 1994. PMID: 7917322 Review.
PrPC controls epithelial-to-mesenchymal transition in EGFR-mutated NSCLC: implications for TKI resistance and patient follow-up.
Lailler C, Didelot A, Garinet S, Berthou H, Sroussi M, de Reyniès A, Dedhar S, Martin-Lannerée S, Fabre E, Le Pimpec-Barthes F, Perrier A, Poindessous V, Mansuet-Lupo A, Djouadi F, Launay JM, Laurent-Puig P, Blons H, Mouillet-Richard S. Lailler C, et al. Among authors: fabre e. Oncogene. 2024 Sep;43(37):2781-2794. doi: 10.1038/s41388-024-03130-0. Epub 2024 Aug 15. Oncogene. 2024. PMID: 39147880 Free PMC article.
251 results